|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
|
US20030157187A1
(en)
*
|
1996-12-02 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing inflammatory diseases
|
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
|
US20030087954A1
(en)
*
|
1997-01-07 |
2003-05-08 |
Sonus Pharmaceuticals, Inc. |
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
|
US6727280B2
(en)
*
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
|
US6844004B2
(en)
|
1997-08-15 |
2005-01-18 |
Board Of Regents, The University Of Texas System |
Topical formulations of natamycin/pimaricin
|
|
US6045815A
(en)
*
|
1997-08-15 |
2000-04-04 |
Board Of Regents, The University Of Texas System |
Parenteral pimaricin as treatment of systemic infections
|
|
ES2324378T3
(es)
*
|
1998-02-05 |
2009-08-05 |
Novartis Ag |
Composicion farmaceutica que contiene epotilona.
|
|
IL131217A0
(en)
*
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
KR19990075621A
(ko)
*
|
1998-03-23 |
1999-10-15 |
임성주 |
경사 평판형 배양조
|
|
KR100446959B1
(ko)
*
|
1998-04-02 |
2004-11-03 |
김종국 |
파클리탁셀주사제조성물
|
|
US7030155B2
(en)
*
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6017948A
(en)
*
|
1998-10-30 |
2000-01-25 |
Supergen, Inc. |
Water-miscible pharmaceutical compositions
|
|
CA2356959C
(en)
*
|
1998-12-22 |
2009-03-31 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Water-insoluble drug delivery system
|
|
US6040330A
(en)
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
|
US6121257A
(en)
*
|
1999-03-31 |
2000-09-19 |
Abbott Laboratories |
Sulfamate containing macrocyclic immunomodulators
|
|
EP2289549A3
(en)
|
1999-10-01 |
2011-06-15 |
Immunogen, Inc. |
Immunoconjugates for treating cancer
|
|
SE9903831D0
(sv)
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
JP2003521545A
(ja)
*
|
2000-02-02 |
2003-07-15 |
フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド |
改良された溶解性を有するタキサン製剤
|
|
AU2001258872C1
(en)
|
2000-05-12 |
2005-05-26 |
Samyang Biopharmaceuticals Corporation |
Method for the preparation of polymeric micelle via phase separation of block copolymer
|
|
US7217770B2
(en)
*
|
2000-05-17 |
2007-05-15 |
Samyang Corporation |
Stable polymeric micelle-type drug composition and method for the preparation thereof
|
|
WO2002009695A1
(en)
*
|
2000-08-02 |
2002-02-07 |
Atossa Healthcare, Inc. |
Bimodal emulsions of taxanes and butyrate polyalcohol esters
|
|
US6919370B2
(en)
*
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
|
EP1435908A4
(en)
*
|
2001-09-13 |
2006-03-15 |
Korea Inst Sci & Tech |
Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
|
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
|
AU2002365883A1
(en)
*
|
2001-11-30 |
2003-06-17 |
Bristol-Myers Squibb Company |
Paclitaxel solvates
|
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
US20050129719A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Yu-Fang Hu |
Concentrated emulsion formulation for silatecan
|
|
US20050220835A1
(en)
*
|
2004-03-30 |
2005-10-06 |
Jayaraman Ramesh B |
Agent eluting bioimplantable devices and polymer systems for their preparation
|
|
BRPI0515573A
(pt)
*
|
2004-09-22 |
2008-07-29 |
Nippon Kayaku Kk |
copolìmero por blocos, preparação de micela e agente anticáncer contendo a mesma como o ingrediente ativo
|
|
WO2007014445A1
(en)
*
|
2005-08-02 |
2007-02-08 |
Miv Therapeutics Inc. |
Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
|
|
KR20080106254A
(ko)
*
|
2006-03-28 |
2008-12-04 |
니폰 가야꾸 가부시끼가이샤 |
탁산류의 고분자 결합체
|
|
AU2007252678A1
(en)
|
2006-05-18 |
2007-11-29 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of podophyllotoxin
|
|
WO2008041610A1
(fr)
*
|
2006-10-03 |
2008-04-10 |
Nippon Kayaku Kabushiki Kaisha |
Mélange d'un dérivé de résorcinol avec un polymère
|
|
EP2080779B1
(en)
|
2006-11-06 |
2016-05-18 |
Nippon Kayaku Kabushiki Kaisha |
Polymeric derivative of nucleic acid metabolic antagonist
|
|
WO2008056654A1
(fr)
|
2006-11-08 |
2008-05-15 |
Nippon Kayaku Kabushiki Kaisha |
Dérivé polymère d'un antagoniste métabolique d'acide nucléique
|
|
EP2206502B1
(en)
|
2007-09-28 |
2018-09-12 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of steroid
|
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
|
KR101589582B1
(ko)
*
|
2008-03-18 |
2016-01-28 |
니폰 가야꾸 가부시끼가이샤 |
생리활성물질의 고분자량 결합체
|
|
US9149540B2
(en)
|
2008-05-08 |
2015-10-06 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of folic acid or folic acid derivative
|
|
EP2431403B1
(en)
|
2009-05-15 |
2016-09-28 |
Nipponkayaku Kabushikikaisha |
Polymer conjugate of bioactive substance having hydroxy group
|
|
CN102038634B
(zh)
*
|
2009-10-23 |
2014-12-10 |
天士力控股集团有限公司 |
一种含有助溶剂的紫杉烷类药物溶液及其制备方法
|
|
CN102038635A
(zh)
*
|
2009-10-23 |
2011-05-04 |
天津天士力集团有限公司 |
一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
|
|
CN102038636B
(zh)
*
|
2009-10-23 |
2014-08-13 |
天士力控股集团有限公司 |
一种含有螯合剂的紫杉烷类药物溶液及其制备方法
|
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前－乳劑調配物及其製造與使用之方法
|
|
JP5824511B2
(ja)
|
2010-05-03 |
2015-11-25 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
|
|
TWI472340B
(zh)
*
|
2010-11-10 |
2015-02-11 |
Tasly Holding Group Co Ltd |
Taxanes containing solution and a preparation method of the co-solvent
|
|
CA2816997A1
(en)
|
2010-11-17 |
2012-05-24 |
Nippon Kayaku Kabushiki Kaisha |
Novel polymer derivative of cytidine metabolic antagonist
|
|
BR112014005452B1
(pt)
*
|
2011-09-11 |
2021-03-16 |
Nippon Kayaku Kabushiki Kaisha |
método de produção de copolímero de bloco
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
CN109464382B
(zh)
*
|
2019-01-08 |
2020-10-09 |
四川大学 |
一种可注射的高载药量的紫杉醇凝胶及其制备方法和应用
|
|
JP2024537910A
(ja)
*
|
2021-10-21 |
2024-10-16 |
カシーヴ バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー |
安定した希釈準備済みカルフィルゾミブ組成物
|